Articles in Stocks

Zacks.com

Raven Downgraded to Strong Sell - Analyst Blog

On May 31, Zacks Investment Research downgraded Raven Industries Inc. ( RAVN ) to Zacks Rank #5 (Strong Sell). Why the Downgrade? Raven Industries' share price and earnings estimates... Read >>

Zacks.com

CRL for Endo Health's Aveed - Analyst Blog

The US Food and Drug Administration (FDA) recently issued a complete response letter (CRL) for Endo Health Solutions ' ( ENDP ) new drug application on Aveed. The company is looking to get... Read >>

Zacks.com

Manitex's Unit Wins $37M Contract - Analyst Blog

Manitex Liftking, a unit of Manitex International, Inc. ( MNTX ), has secured a $37 million contract from US Military for a period of five years to supply specialized material handling... Read >>

Zacks.com

Glaxo Reports Votrient Data - Analyst Blog

GlaxoSmithKline ( GSK ) recently announced data from a phase III trial (n = 940) evaluating its oncology drug, Votrient (pazopanib). The randomized, double-blind, placebo-controlled phase... Read >>

Zacks.com

Xcel Plans to Add Wind Assets - Analyst Blog

Xcel Energy Inc. ( XEL ) announced positive results for its Request for Proposals ("RPF") for expanding renewable generation assets in the state of Colorado. In response to the... Read >>

Zacks.com

NCR to Make Mobile Ordering Simpler - Analyst Blog

ATM manufacturer NCR Corporation ( NCR ) is soon to announce another innovation. The company said it is working with Jamba Juice ( JMBA ) and PayPal to launch a series of mobile... Read >>

Zacks.com

Supervalu Closes Sale of Notes - Analyst Blog

Leading grocer Supervalu Inc. ( SVU ) has announced the expiration of the senior notes offer worth $300 million due on May 1, 2016. On May 2, 2013, Supervalu commenced the sale of a... Read >>

Zacks.com

Assured Guaranty to Buy Back Shares - Analyst Blog

Assured Guaranty Ltd. ( AGO ) will buy back 5 million shares from WL Ross & Co. LLC and its affiliates (together known as WLR) for $21.94 per share. The purchase price translates... Read >>

Zacks.com

Shire Settles Lawsuit with Teva - Analyst Blog

Shire LLC ( SHPG ) recently announced the settlement of its patent infringement lawsuit against Teva Pharmaceuticals ( TEVA ) for Shire's attention deficit hyperactivity disorder (ADHD)... Read >>

Zacks.com

CHMP Positive on Aegerion's Lojuxta - Analyst Blog

Aegerion Pharmaceuticals, Inc. ( AEGR ) recently received a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) for Lojuxta (lomitapide). The company is looking... Read >>